Some of the cancer modelling work of Claire Villette was presented at the American Association for Cancer research (AACR) 2023 meeting, which took place on April 14-19, 2023 in Orlando, Florida, USA. This research is part of a collaborative work with the companies Pysiomics PLC (Oxford, UK), Merck KGaA (Darmstadt, Germany) and EMD Serono (Billerica, MA, USA).

Her work was shown as oral presentation with the title “Development and validation of a quantitative systems pharmacology model for prediction of preclinical efficacy of PARP inhibitors rucaparib and talazoparib combined with the ATR inhibitor gartisertib (M4344)”. The full presentation is available to download here.